Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Invests in the Future of Parkinson's Research

Support Provided for the Next Generation of Movement Disorder Neurologists

MIAMI,FL — Continuing its commitment to invest in the future of Parkinson's research, the National Parkinson Foundation (NPF) announced today two new awards to support promising young Parkinson's disease researchers. With the support of The McCamish Charitable Fund, NPF awarded a fellowship for training neurologists in the field of movement disorders and a research grant to help young faculty to accelerate their scientific careers. 

"Today, young scientists are under more pressure than ever before.  Awards like these are critical in helping to encourage the next generation to pursue careers in scientific innovation in the treatment of Parkinson's disease," said Michael Okun, MD, NPF's National Medical Director. "The lab breakthroughs happening now will rely on the next generation of scientists to usher them through the FDA process and into widespread adoption."

The 2015 NPF McCamish Fellowship Award was presented to Joash T. Lazarus, MD, by the HFM Foundation. Dr. Lazarus is currently chief resident in neurology at Emory University School of Medicine in Atlanta, GA, an NPF Center of Excellence. He was nominated by Stewart Factor, DO, Director of the Emory NPF Center of Excellence. The two-year clinical and research fellowship in movement disorders totals $120,000. 

"Due to the constriction in availability of research funding, it is increasingly difficult for young researchers to begin their careers with new ideas," said Peter Schmidt, PhD, NPF's Chief Information Officer and Vice President of Research and Professional Programs. "The best investment in future research innovation is to provide the support necessary for a young researcher to set aside time to conduct research."

The 2015 NPF McCamish Young Investigator Award was presented to James W. Maas, MD, PhD, by the MPM Foundation. Dr. Maas is currently an Assistant Clinical Professor in the department of neurology at University of California, San Francisco (UCSF), an NPF Center of Excellence. He was nominated by Michael Aminoff, MD, Director of the UCSF NPF Center of Excellence. The year-long research award totals $25,000. 

NPF's Center of Excellence network, which includes Emory and UCSF, features world-renowned Parkinson's specialists focused on reaching across patient and professional communities to change the course of Parkinson's disease. The network serves more than 50,000 individuals diagnosed with Parkinson's. NPF has designated 41 Centers of Excellence around the world. To view a full listing of centers, visit www.parkinson.org/coe

About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Monday, March 2, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.